M. Mateo Paz Soldán,
MD, PhD
Languages Spoken: English
Dr. Paz Soldán is assistant professor in the Neuroimmunology Division of Neurology at the University of Utah. His clinical interests focus on multiple sclerosis (MS), neuromyelitis optica (NMO), and other inflammatory or demyelinating diseases of the central nervous system. His interests extend to autoimmune neurologic diseases—those primarily affecting the nervous system, those occurring with rheumatologic disease, and those occurring in the setting of cancer (paraneoplastic). He also has interest in general clinical neurology.
Clinical Locations
801-585-7575
Board Certification and Academic Information
| Academic Departments | Neurology
-
Assistant Professor |
| Academic Divisions | Neuroimmunology |
| Board Certification | American Board of Psychiatry & Neurology (Neurology) |
Patient Rating
The Patient Rating score is an average of all responses to care provider related questions on our nationally-recognized Press Ganey Patient Satisfaction Survey.
Responses are measured on a scale of 1 to 5 with 5 being the best score.
Likelihood of recommending care provider
4.7/ 5
Care provider's explanation of condition/problem
4.6/ 5
Care provider's effort to include me in decisions
4.7/ 5
Wait time at clinic
4.1/ 5
Care provider's concern for questions & worries
4.7/ 5
Patient Comments
Patient comments are gathered from our Press Ganey Patient Satisfaction Survery and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.
UofU Patient
March 11, 2022
CLINICAL NEUROSCIENCES CENTER
Very happy with my care.
UofU Patient
March 07, 2022
CLINICAL NEUROSCIENCES CENTER
Good
UofU Patient
February 24, 2022
CLINICAL NEUROSCIENCES CENTER
Everyone was amazing. I could not have asked for a better experience.
UofU Patient
December 16, 2021
CLINICAL NEUROSCIENCES CENTER
Good
UofU Patient
November 08, 2021
CLINICAL NEUROSCIENCES CENTER
Dr. Paz Soldan is the first neurologist I've had in 19 years to recommend physical therapy & I'm really excited about it!
UofU Patient
September 20, 2021
CLINICAL NEUROSCIENCES CENTER
Excellent care
UofU Patient
July 19, 2021
IMAGING AND NEUROSCIENCES CENTER
Doctor Paz-soldan is a great doctor. Listens to questions and gives clear answers.
UofU Patient
July 19, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr Paz-Soldan wass awesome s always. I always feel great about where I am in my ms journey after my appointments. Dr Paz-Soldan makes sure I am informed about any switching regarding medications treatments ect.
UofU Patient
July 12, 2021
IMAGING AND NEUROSCIENCES CENTER
Very knowledgeable Dr. and Nurse
UofU Patient
July 08, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr P ask if I agreed with his treatment plan!
UofU Patient
April 28, 2021
IMAGING AND NEUROSCIENCES CENTER
the waiting time was too long.
UofU Patient
April 19, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr Paz-Soldan is by far the best neurologist I have seen. He makes sure I understand everything he says or orders. he takes time to answer any questions I might have.
UofU Patient
April 05, 2021
IMAGING AND NEUROSCIENCES CENTER
Both doctor's were great at these things! Poon and Paz-Saldon
UofU Patient
March 29, 2021
IMAGING AND NEUROSCIENCES CENTER
love the team! Dr Abbatemarco is a Fantastic fellow. Sad to see him go after the end of his fellowship. also love Dr Paz Soldan! so happy with my care at the U!
UofU Patient
March 24, 2021
IMAGING AND NEUROSCIENCES CENTER
the doctor is unfriendly and vague
UofU Patient
March 24, 2021
IMAGING AND NEUROSCIENCES CENTER
great communication
UofU Patient
March 11, 2021
IMAGING AND NEUROSCIENCES CENTER
the woman I saw in place of the Dr I came to see was very thorough. the Dr came in (which is who this survey is about)for 10 min and was not. he was dismissive and told me I didn't have what I was already diagnosed with.
UofU Patient
January 11, 2021
IMAGING AND NEUROSCIENCES CENTER
Dr Paz Soldan and his fellow Dr Poon helped guide me through decisions at a time when I'm very nervous about my health. I left with a feeling that I'm taking back control of my health and I can't thank them enough for the time that they took to get me there.
UofU Patient
November 03, 2020
IMAGING AND NEUROSCIENCES CENTER
Very professional and friendly providers.
Dr. Paz Soldán is assistant professor in the Neuroimmunology Division of Neurology at the University of Utah. His clinical interests focus on multiple sclerosis (MS), neuromyelitis optica (NMO), and other inflammatory or demyelinating diseases of the central nervous system. His interests extend to autoimmune neurologic diseases—those primarily affecting the nervous system, those occurring with rheumatologic disease, and those occurring in the setting of cancer (paraneoplastic). He also has interest in general clinical neurology.
Academic Locations
Board Certification and Academic Information
| Academic Departments | Neurology
-
Assistant Professor |
| Academic Divisions | Neuroimmunology |
| Board Certification | American Board of Psychiatry & Neurology (Neurology) |
Education History
| Fellowship | Mayo School of Graduate Medical Education Multiple Sclerosis / Neuroimmunology Fellow, 2014 |
| Residency | Mayo School of Graduate Medical Education Neurology Resident, 2012 |
| Internship | Mayo School of Graduate Medical Education Preliminary Internal Medicine Intern, 2009 |
| Professional Medical | Mayo Medical School Medicine M.D., 2008 |
| Postdoctoral Fellowship | Sun Health Research Institute Postdoctoral Fellow, 2004 |
| Doctoral Training | Mayo Graduate School Biomedical Sciences - Molecular Neuroscience Ph.D., 2002 |
| Graduate Training | Arizona State University Zoology - Biophysics M.S., 1996 |
| Undergraduate | Arizona State University Zoology B.S., 1994 |
Selected Publications - Journal Articles
Journal Article
- Abbatemarco JR, Galli JR, Sweeney ML, Carlson NG, Samara VC, Davis H, Rodenbeck S, Wong KH, Paz Soldan MM, Greenlee JE, Rose JW, Delic A, Clardy SL (2021). Modern Look at Transverse Myelitis and Inflammatory Myelopathy: Epidemiology of the National Veterans Health Administration Population. Neurol Neuroimmunol Neuroinflamm, 8(6).
- Kassa RM, Sechi E, Flanagan EP, Kaufmann TJ, Kantarci OH, Weinshenker BG, Mandrekar J, Schmalstieg WF, Paz Soldan MM, Keegan BM (2020). Onset of progressive motor impairment in patients with critical central nervous system demyelinating lesions. Mult Scler, 27(6), 895-902.
- Hauser SL, Bar-Or A, Cohen JA, Comi G, Correale J, Coyle PK, Cross AH, de Seze J, Leppert D, Montalban X, Selmaj K, Wiendl H, Kerloeguen C, Willi R, Li B, Kakarieka A, Tomic D, Goodyear A, Pingili R, Hring DA, Ramanathan K, Merschhemke M, Kappos L, ASCLEPIOS I and ASCLEPIOS II Trial Groups (2020). Ofatumumab versus Teriflunomide in Multiple Sclerosis. N Engl J Med, 383(6), 546-557.
- Lord J, Paz Soldan MM, Galli J, Salzman KL, Kresser J, Bacharach R, DeWitt LD, Klein J, Rose J, Greenlee J, Clardy SL (2020). Neurosarcoidosis: Longitudinal experience in a single-center, academic healthcare system. Neurol Neuroimmunol Neuroinflamm, 7(4).
- Hollen CW, Paz Soldn MM, Rinker JR 2nd, Spain RI (2020). The Future of Progressive Multiple Sclerosis Therapies. Fed Pract, 37(Suppl 1), S43-S49.
- Piquet AL, Khan M, Warner JEA, Wicklund MP, Bennett JL, Leehey MA, Seeberger L, Schreiner TL, Paz Soldan MM, Clardy SL (2019). Novel clinical features of glycine receptor antibody syndrome: A series of 17 cases. Neurol Neuroimmunol Neuroinflamm, 6(5), e592.
- Toledano M, Weinshenker BG, Kaufmann TJ, Parisi JE, Paz Soldn MM (2018). Demographics and clinical characteristics of episodic hypothermia in multiple sclerosis. Mult Scler, 25(5), 709-714.
- Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP (2018). Progressive motor impairment from a critically located lesion in highly restricted CNS-demyelinating disease. Mult Scler, 24(11), 1445-1452.
- Galli JR, Clardy SL, Paz Soldn MM (2016). Adult-onset Opsoclonus-Myoclonus Syndrome Associated With Ganglionic Acetylcholine Receptor Autoantibody. Neurologist, 21(6), 99-100.
- Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP (2016). Progressive solitary sclerosis: Gradual motor impairment from a single CNS demyelinating lesion. Neurology, 87(16), 1713-1719.
- Novotna M, Paz Soldn MM, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Noseworthy JH, Weinshenker BG, Rodriguez M, Kantarci OH (2015). Poor early relapse recovery affects onset of progressive disease course in multiple sclerosis. Neurology, 85(8), 722-9.
- Paz Soldn MM, Raman MR, Gamez JD, Lohrey AK, Chen Y, Pirko I, Johnson AJ (2015). Correlation of Brain Atrophy, Disability, and Spinal Cord Atrophy in a Murine Model of Multiple Sclerosis. J Neuroimaging, 25(4), 595-9.
- Paz Soldn MM, Novotna M, Abou Zeid N, Kale N, Tutuncu M, Crusan DJ, Atkinson EJ, Siva A, Keegan BM, Pirko I, Pittock SJ, Lucchinetti CF, Weinshenker BG, Rodriguez M, Kantarci OH (2015). Relapses and disability accumulation in progressive multiple sclerosis. Neurology, 84(1), 81-8.
- Paz Soldn MM, Pittock SJ, Weigand SD, Yawn BP, Rodriguez M (2012). Statin therapy and multiple sclerosis disability in a population-based cohort. Mult Scler, 18(3), 358-63.
- Ciric B, Van Keulen V, Paz Soldan M, Rodriguez M, Pease LR (2004). Antibody-mediated remyelination operates through mechanism independent of immunomodulation. J Neuroimmunol, 146(1-2), 153-61.
- Ciric B, Howe CL, Paz Soldan M, Warrington AE, Bieber AJ, Van Keulen V, Rodriguez M, Pease LR (2003). Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol, 13(4), 608-16.
- Paz Soldn MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M (2003). Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci, 22(1), 14-24.
- Mitsunaga Y, Ciric B, Van Keulen V, Warrington AE, Paz Soldan M, Bieber AJ, Rodriguez M, Pease LR (2002). Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J, 16(10), 1325-7.
- Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Mitsunaga Y, Paz Soldan MM, Rodriguez M (2001). Immunoglobulin-mediated CNS repair. J Allergy Clin Immunol, 108(4 Suppl), S121-5.
Review
- Paz Soldan MM, Pirko I (2012). Biogenesis and significance of central nervous system myelin. [Review]. Semin Neurol, 32(1), 9-14.
- Paz Soldan MM, Rodriguez M (2002). Heterogeneity of pathogenesis in multiple sclerosis: implications for promotion of remyelination. [Review]. J Infect Dis, 186 Suppl 2, S248-53.
Book Chapter
- Baldassari LE, Paz Soldan MM (2021). Natural History of Multiple Sclerosis. In Piquet AL, Alvarez E (Eds.), Neuroimmunology: Multiple Sclerosis, Autoimmune Neurology and Related Diseases (1st, pp. 535 pages). Switzerland: Springer International Publishing.
Editorial
Abstract
- Waslo CS, Paz Soldan MM, Freedman MS, Repovic P, Solomon AJ, Rinker JR, Wallin MT, Haselkorn JK, Spain RI (2020). Challenges and Opportunities in Progressive Multiple Sclerosis Trials: Lessons from Lipoic Acid [Abstract]. 22(s2), 10-11.
- Esquibel L, De Almeida B, Millsap L, Galli J, Gundlapalli A, Paz Soldan MM, Klein J, Cortez M, Rose J, Greenlee J, Hill H, Wong K, Clardy SL (2020). Evaluation of the Prevalence of Headache and Pain of Unknown Cause in Patients with Common Variable Immunodeficiency (CVID) [Abstract]. 94(15 Suppl.), 794.
- Kadish R, Wong K, Galli J, Greenlee J, Klein J, Paz Soldan MM, Clardy S, Rose J (2020). Characterization of Retinal Nerve Fiber Layer Thickness in a Cohort with Anti-Glutamic Acid Decarboxylase and Anti-Glycine Receptor Autoimmunity [Abstract]. 94(15 Suppl.), 2227.
- Kassa RM, Sechi E, Flanagan EP, Kaufmann TJ, Kantarci OH, Weinshenker BG, Mandrekar J, Schmalstieg WF, Paz Soldan MM, Keegan BM (2020). Onset of Progressive Motor Impairment in Patients with Critical CNS Demyelinating Lesions [Abstract]. 94(15 Suppl.), 4405.
- De Almeida BI, Esquibel L, Millsap L, Klein J, Galli J, Cortez MM, Paz Soldan MM, Gundlapalli A, Greenlee J, Rose J, Hill H, Wong K, Clardy S (2020). Cognitive and Depressive Symptoms in Adults with Common Variable Immunodeficiency (CVID) [Abstract]. 94(15 Suppl.), 4502.
- Steiner S, Durman G, Paz Soldan MM, Woltz S, Wong K, Rose J (2020). Neurogenic Pain in Multiple Sclerosis: A Single Center Comprehensive Pain Assessment [Abstract]. 94(15 Suppl.), 4592.
- Wong K, Bacharach R, Klein J, Paz Soldan MM, Rose J (2020). Longitudinal Assessment of Optical Coherence Tomography in Patients with Relapsing-Remitting Multiple Sclerosis on Three Disease Modifying Therapies. Neurology [Abstract]. 94(15 Suppl.), 4691.
- De Almeida BI, Wong K, Millsap L, Cortez M, Greenlee JE, Gundlapalli A, Hill H, Paz Soldan MM, Rose J, Galli J, Clardy SL (2019). Neurological Manifestations in Common Variable Immunodeficiency [Abstract]. 86(Suppl. 24), S36 (S108).
- Kassa RM, Sechi E, Flanagan EP, Weinshenker BG, Kantarci OH, Kaufmann TJ, Schmalstieg WF, Paz Soldan MM, Keegan BM (2019). Age of onset of progressive motor impairment in patients with critical demyelinating lesions [Abstract]. 25(Suppl. 2), 673 (P1243).
- Klonoski J, Palmer C, Clardy S, Paz Soldan MM, Lancaster E, Peterson L (2019). Histopathologic presentation of two cases of GABAa-R autoimmune encephalitis [Abstract]. 78(6), 575 (P218).
- Wong K, Bacharach R, Marini E, Nguyen T, Clardy S, Cortez M, DeWitt LD, Greenlee J, Klein J, Paz Soldan MM, Steffens J, Rose J (2019). Dimethyl Fumarate Dose Reduction in Lymphopenic Relapsing Remitting Multiple Sclerosis Patients: Clinical and MRI Outcomes [Abstract]. 92(15 Suppl.), P4.2-013.
- Galli J, Piquet A, Kresser J, Klein J, Warner J, Digre K, Peterson L, Tebo A, Haven T, Paz Soldan MM, Rose J, Greenlee J, Clardy S (2019). GAD65 and Glycine Receptor-Associated Neurologic Autoimmunity and Stiff-Person Syndrome within the University of Utah Health Care System [Abstract]. 92(15 Suppl.), P2.2-036.
- Lord J, Bacharach R, Galli J, Kresser J, Klein J, DeWitt LD, Paz Soldan MM, Rose J, Greenlee J, Clardy S (2019). Neurosarcoidosis: Longitudinal Experience in a Single-Center, Academic Health Care System [Abstract]. 92(15 Suppl.), P1.2-046.
- Piquet AL, Khan M, Warner JEA, Wicklund MP, Leehey MA, Schreiner T, Paz Soldan MM, Clardy SL (2018). Clinical Features of Glycine Receptor Antibody Syndrome: A Series of Eleven Cases [Abstract]. Annals of Neurology, 84(Suppl. 22), S1.
- Waheed MO, Wong K, Clardy SL, Cortez MM, Dewitt LD, Klein JM, Paz Soldan MM, Steffens JD, Rose JW (2018). Transition from Natalizumab to Dimethyl Fumarate in Multiple Sclerosis Patients: Clinical and Magnetic Resonance Imaging Outcomes [Abstract]. International Journal of MS Care, 20(Suppl. 1), 29-30.
- Wong K, Marini E, Nguyen TP, Clardy SL, Cortez MM, DeWitt LD, Greenlee JE, Klein JM, Paz Soldan MM, Steffens JD, Rose JW (2018). Dimethyl Fumarate in Relapsing Remitting Multiple Sclerosis: 24 Months Observations of the Effects of Dose Reduction on Lymphopenia [Abstract]. Neurology, 90(15 Suppl.), P6.347.
- Williams JP, Street M, Badger JK, Peterson LK, Greenlee JE, Carlson NG, Rose JW, Paz Soldan MM, Clardy SL (2018). Characterization and Alternative Diagnoses in Patients with False-positive Aquaporin-4 Autoantibody Detection by Enzyme-Linked Immunosorbent Assay (ELISA) [Abstract]. Neurology, 90(15 Suppl.), P6.420.
- Williams JP, Galli JR, Groshans KA, Horvat DE, Austin S, Pittock SJ, Rose JW, Carlson NG, Greenlee JE, Paz Soldan MM, Tagg NT, Clardy SL (2018). Neuromyelitis Optica Spectrum Disorder (NMOSD) in Active Duty Service Members [Abstract]. Neurology, 90(15 Suppl.), P6.424.
- Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP (2018). Progressive Motor Impairment from a Critically Located Lesion in Highly Restricted CNS Demyelinating Disease [Abstract]. Neurology, 90(15 Suppl.), P5.034.
- Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP (2017). Motor progression from a single critically located demyelinating lesion in paucisclerotic MS [Abstract]. Multiple Sclerosis Journal, 23(Suppl. 3), 437.
- Carlson NG, Schmidt LA, Wood B, Clendennon C, Weber LM, Paz Soldan MM, Rose JW (2017). Remyelination following oral administration of dimethyl fumarate in the Theiler’s murine encephalomyelitis virus model of multiple sclerosis [Abstract]. Multiple Sclerosis Journal, 23(Suppl. 3), 622.
- Baldassari LE, Seraj H, Husebye CD, Paz Soldn MM, Martins TB, Carlson NG, Rose JW (2017). Cytokine Profiles Across DR2 Haplotype and Vitamin D Status in the Intermountain Multiple Sclerosis Project [Abstract]. 2017 Annual Meeting of the Consortium of Multiple Sclerosis Centers, ND03.
- Piquet AL, Baldassari LE, Paz Soldn MM (2017). Highly active relapsing remitting multiple sclerosis following hematopoietic stem cell transplantation: a case report [Abstract]. Neurology, 88(16 Suppl.), P6.355.
- Wong K, Marini E, Clardy SL, DeWitt LD, Klein JM, Paz Soldan MM, Rose JW (2017). Dimethyl Fumarate in Relapsing Remitting Multiple Sclerosis: Effects of Dose Reduction on Lymphopenia [Abstract]. Neurology, 88(16 Suppl.), P5.373.
- Baldassari LE, Seraj H, Husebye CD, Paz Soldn MM, Martins TB, Carlson NG, Rose JW (2017). Baseline characteristics and cytokine profiles across demographic subsets in the Intermountain Multiple Sclerosis Project [Abstract]. Neurology, 88(16 Suppl.), P1.382.
- Samara VC, Sweeney M, Carlson H, Paz Soldan MM, Greenlee JE, Carlson NG, Rose JW, Clardy SL (2016). Transverse Myelitis in Veterans [Abstract]. Annals of Neurology, 80(Suppl. 20), S203.
- Conway BL, Zeydan B, Novotna M, Paz Soldan MM, Tutuncu M, Siva A, Rodriguez M, Kantarci OH (2016). Amount and time to maximal recovery from multiple sclerosis relapses declines with age [Abstract]. Multiple Sclerosis Journal, 22(Suppl. 3), 111.
- Carlson NG, Schmidt LA, Wood B, Clendennen C, Weber LM, Paz Soldan MM, Rose JW (2016). Therapeutic effects of oral dimethyl fumarate in the Thiler's murine encephalomyelitis virus model of multiple sclerosis [Abstract]. Multiple Sclerosis Journal, 22(Suppl. 3), 163.
- Carlson H, Haringer V, Sweeney M, Rose JW, Carlson NG, Greenlee JE, Paz Soldan MM, Clardy SL (2016). Transverse Myelitis in Veterans: Epidemiology and Outcomes [Abstract]. Neurology, 86(16 Suppl.), P6.129.
- Sweeney ML, Paz Soldan MM, Lowichik A, Sweney MT, Clardy SL (2016). A Pediatric Patient with ANNA-1 Associated Opsoclonus Myoclonus and Epilepsia Partialis Continua [Abstract]. Neurology, 86(16 Suppl.), P5.137.
- Galli J, Greenlee JE, Paz Soldan MM, Clardy SL (2016). Epidemiology of Stiff Person Syndrome in the United States Veterans Health Administration Database [Abstract]. Neurology, 86(16 Suppl.), P3.356.
- Keegan BM, Kaufmann TJ, Weinshenker BG, Kantarci OH, Schmalstieg WF, Paz Soldan MM, Flanagan EP (2016). Progressive Solitary Sclerosis: Insidious Motor Impairment Localized to an Isolated CNS Demyelinating Lesion [Abstract]. Neurology, 86(16 Suppl.), P3.008.
- Novotna M, Conway B, Zeydan B, Paz Soldan MM, Abou Zeid N, Kale N, Tutuncu M, Kantarci OH (2016). Predicting the End of Symptomatic Relapses and Disease Modifying Treatment Use Decisions in Progressive Multiple Sclerosis [Abstract]. Neurology, 86(16 Suppl.), S24.001.
- Carlson NG, Schmidt L, Redd J, Bellamkonda S, Wood B, Weber LM, Paz Soldn MM, Rose JW (2015). Vulnerability of oligodendrocyte precursor cells to death is modulated by key prostaglandins [Abstract]. Multiple Sclerosis Journal, 21(Suppl. 11), 467-468.
- Novotna M, Paz Soldn MM, Abou Zeid N, Kale N, Tutuncu M, Kantarci OH (2015). Defining the overlapping period of relapsing-remitting and progressive phases of multiple sclerosis for continuing disease modifying treatments [Abstract]. Multiple Sclerosis Journal, 21(Suppl. 11), 91-92.
- Toledano M, Weinshenker BG, Paz Soldn MM (2015). Demographics and characteristics of multiple sclerosis-related hypothermia [Abstract]. Multiple Sclerosis Journal, 21(Suppl. 11), 729-730.
- Galli JR, Clardy SL, Paz Soldn MM (2015). Ganglionic acetylcholine receptor autoantibody-associated opsoclonus-myoclonus syndrome [Abstract]. Annals of Neurology, 78(Suppl. 19), S75.
- Paz Soldn MM, Schmidt LA, Wood BL, Rose JW, Carlson NG (2015). Prostaglandin F2α Receptor Mediates Oligodendrocyte Precursor Injury/Death: Potential Role in Multiple Sclerosis [Abstract]. Neurology, 84(14 Suppl.), P5.210.
- Paz Soldan MM, Flanagan EP, Kantarci OH (2014). Highly active multiple sclerosis and Epstein-Barr virus reactivation [Abstract]. Mult Scler, 20(Suppl. 1), 229-230.
- Paz Soldan MM, Gamez JD, Raman M, Macura SI, Johnson AJ, Pirko I (2014). MRI measured brain and spinal cord atrophy differ between mouse strains in a murine model of MS [Abstract]. ISMRM 2014; Abstract No. 3382.
- Novotna M, Tutuncu M, Paz Soldan MM, Crusan DJ, Atkinson EJ, Kantarci OH (2014). Early relapse-recovery impacts progressive disease course in multiple sclerosis [Abstract]. Neurology, 82(10 Suppl.), S34.006.
- Paz Soldan MM, Martina N, Crusan DJ, Atkinson EJ, Kantarci OH (2013). Pre- and post-progression relapses impact disability in progressive multiple sclerosis [Abstract]. Mult Scler, 19(Suppl. 1), 65.
- Paz Soldan MM, Tutuncu M, Tang J, Abou Zeid N, Kale N, Crusan DJ, Atkinson EJ, Siva A, Pittock SJ, Pirko I, Keegan BM, Lucchinetti CF, Noseworthy JH, Rodriguez M, Weinshenker BG, Kantarci OH (2013). Predicting tempo of post-progression disability accumulation in multiple sclerosis [Abstract]. Neurology, 80(7 Suppl.), P02.147.
- Paz Soldan MM, Gamez JD, Johnson AJ, Lohrey AK, Chen Y, Pirko I (2011). Correlation of brain atrophy, disability and spinal cord atrophy in a murine model of MS [Abstract]. Annals of Neurology, 70(Suppl. 15), S70 (T1715).
- Paz Soldn MM, Rodriguez M (1999). Remyelination promoting antibodies mediate Ca2+ responses in oligodendrocytes [Abstract]. Society for Neuroscience Southern Minnesota Chapter Poster Session, Rochester, MN.